Literature DB >> 1394153

Changes in diagnosis of non-Hodgkin's lymphomas over time.

P M Banks1.   

Abstract

The question is raised as to whether changes in criteria for the diagnosis of non-Hodgkin's lymphomas, both clinical and pathological, have changed over the past four decades in sufficient scale to create a spurious increase in the apparent incidence of this grouping of disease. In the decade of the 1970s refinement in histomorphological criteria for the diagnosis of Hodgkin's disease resulted in as many as 10-15% of cases which previously would have been diagnosed as Hodgkin's disease being diagnosed instead as non-Hodgkin's lymphoma. Other considerations, including distinction of non-Hodgkin's lymphomas from leukemias and plasma cell myelomas, and recent recognition of angioimmunoblastic lymphadenopathy and extranodal "pseudolymphomas" as variant forms of non-Hodgkin's lymphoma, appear to have added only marginally to the total of reported cases. It is concluded that the increase in reported incidence of non-Hodgkin's lymphoma cannot be explained on the basis of changes in diagnostic criteria.

Entities:  

Mesh:

Year:  1992        PMID: 1394153

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.

Authors:  T Mitterlechner; M Fiegl; H Mühlböck; W Oberaigner; S Dirnhofer; A Tzankov
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

Review 2.  Vitamin D and non-Hodgkin lymphoma risk in adults: a review.

Authors:  Jennifer L Kelly; Jonathan W Friedberg; Laura M Calvi; Edwin van Wijngaarden; Susan G Fisher
Journal:  Cancer Invest       Date:  2009-11       Impact factor: 2.176

3.  Perinatal and family risk factors for non-Hodgkin lymphoma in early life: a Swedish national cohort study.

Authors:  Casey Crump; Kristina Sundquist; Weiva Sieh; Marilyn A Winkleby; Jan Sundquist
Journal:  J Natl Cancer Inst       Date:  2012-05-22       Impact factor: 13.506

Review 4.  Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A J Swerdlow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

Review 5.  Current status of the epidemiologic evidence linking polychlorinated biphenyls and non-hodgkin lymphoma, and the role of immune dysregulation.

Authors:  Shira Kramer; Stephanie Moller Hikel; Kristen Adams; David Hinds; Katherine Moon
Journal:  Environ Health Perspect       Date:  2012-05-02       Impact factor: 9.031

6.  Epidemic of non-hodgkin lymphoma in new zealand remains unexplained.

Authors:  Brian Cox; Chih-Wei Liu; Mary J Sneyd; Claire M Cameron
Journal:  J Cancer Epidemiol       Date:  2014-04-01

7.  Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study.

Authors:  Linghui Zhou; Yujiao Deng; Na Li; Yi Zheng; Tian Tian; Zhen Zhai; Si Yang; Qian Hao; Ying Wu; Dingli Song; Dai Zhang; Jun Lyu; Zhijun Dai
Journal:  J Hematol Oncol       Date:  2019-10-22       Impact factor: 17.388

8.  Trends in cancer incidence and mortality in Scotland: description and possible explanations.

Authors:  A J Swerdlow; I dos Santos Silva; A Reid; Z Qiao; D H Brewster; J Arrundale
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.